Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Mar;19(2):120-8.

The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin

Affiliations

The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin

I Nalepa et al. J Psychiatry Neurosci. 1994 Mar.

Abstract

The aim of this study was to evaluate the effect of mianserin, a second generation tetracyclic antidepressant agent, on the receptors' and second messenger systems related to noradrenergic transmission in the cerebral cortex of the rat. In in vitro experiments we confirmed that mianserin binds with equal potency to alpha 1- and alpha 2-adrenoceptors and does not affect beta 1-adrenoceptors. It inhibited the noradrenaline-stimulated inositol phosphate accumulation and did not change the cyclic AMP responses to noradrenaline and isoproterenol. The drug attenuated the inhibitory action of PKC activator, TPA, on the noradrenergic response from alpha 1-adrenoceptor and the potentiating action of TPA on the cyclic AMP stimulated with noradrenaline and isoproterenol. In chronic experiments we have found that, in contrast to most antidepressants, chronic treatment with mianserin does not produce strong beta-downregulation, but increases the maximal inositol phosphate response from alpha 1-adrenoceptor. The results indicate that alpha 1-upregulation might be a characteristic of those efficient antidepressant drugs which do not produce a strong beta-downregulatory effect.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Life Sci. 1981 Jun 22;28(25):2847-54 - PubMed
    1. J Pharmacol Exp Ther. 1990 Aug;254(2):484-8 - PubMed
    1. Brain Res. 1982 Apr 29;238(2):499-504 - PubMed
    1. J Neurochem. 1991 Sep;57(3):904-10 - PubMed
    1. Pol J Pharmacol Pharm. 1991 May-Jun;43(3):187-95 - PubMed

LinkOut - more resources